Pelizaeus-Merzbacher Disease

This is a rare disease that affects the myelin, which is like the protective coating around nerve fibers. It causes problems with nerve signals, leading to symptoms like tremors, eye movements, and difficulty walking. There are different types, and the symptoms can vary.

Condition

What people with Pelizaeus-Merzbacher Disease report

Every report comes from a Lived member, sent anonymously.

Have you tried Exercise Therapy for Pelizaeus-Merzbacher Disease?

NameHow it went

About Pelizaeus-Merzbacher Disease

What It Is

Pelizaeus-Merzbacher disease (PMD) is a rare inherited condition in which the brain and spinal cord cannot build normal myelin, the fatty coating that insulates nerve fibers and lets signals travel quickly. With too little myelin, messages between nerve cells slow down, which mainly affects movement, coordination, eye control and speech. PMD belongs to a group of genetic white matter disorders called leukodystrophies, and it almost always affects boys. Signs usually appear in infancy. Many babies first show rapid, involuntary eye movements (nystagmus), floppy muscle tone and delays in skills such as holding up the head or sitting. Over time, muscle stiffness (spasticity), poor balance and coordination (ataxia), tremor and involuntary movements often develop. Movement is usually affected more than understanding: people with PMD often understand more than they can show through movement or speech, though understanding also varies with the form. PMD ranges widely in severity. The connatal form starts at or shortly after birth and is the most severe. The classic form, which is more common, begins in the first year and progresses more slowly. A transitional form falls between the two. Milder conditions caused by the same gene, such as spastic paraplegia type 2, mainly cause stiffness and weakness in the legs.

Causes & Risk Factors

PMD is caused by changes in a gene called PLP1, which carries instructions for a protein that makes up much of the myelin in the brain and spinal cord. The most common change is an extra copy of the gene, which leads to too much of the protein. Other changes produce a misshapen protein or none at all. Each of these disrupts the cells that make myelin and leaves nerve fibers poorly insulated and prone to damage. In roughly 5 to 20 percent of people with features of PMD, no PLP1 change is found. The PLP1 gene sits on the X chromosome, so PMD follows an X-linked pattern. Boys have one X chromosome, so one altered copy causes the condition. Girls have two, and a carrier usually has no symptoms or milder ones, such as leg stiffness. When a mother carries the change, each pregnancy has a 50 percent chance of passing it on; a son who inherits it will be affected, and a daughter who inherits it will usually be a carrier. Sometimes the change arises new in a child, with no family history. Nothing a parent did during pregnancy causes PMD.

How It's Diagnosed

PMD is usually suspected when an infant or young child has nystagmus, low muscle tone and delayed motor development. A neurologist examines the child, reviews development and asks about relatives, especially boys on the mother's side, with similar problems. A brain MRI (magnetic resonance imaging) is a key step. It shows that the brain's white matter has not developed its normal myelin, a pattern called hypomyelination. Because other leukodystrophies and conditions such as cerebral palsy can look similar, genetic testing of the PLP1 gene is used to confirm the diagnosis. If no PLP1 change is found, broader genetic testing may look for a look-alike condition, such as Pelizaeus-Merzbacher-like disease, which is caused by a different gene and inherited differently. Once the family's specific gene change is known, genetic counseling can explain what it means for relatives. Female relatives can be tested to see whether they are carriers, and testing during pregnancy or of embryos before IVF (in vitro fertilization) implantation is possible.

Treatment Options

There is currently no cure for PMD and no approved treatment that changes its course. Care focuses on comfort, function, nutrition and preventing complications, and it works best when a coordinated team is involved, often including neurology, rehabilitation medicine, orthopedics, lung and digestive specialists, and therapists. Physical and occupational therapy help maintain movement, prevent joints from tightening and make daily activities easier, supported by braces, seating and mobility equipment. Muscle relaxants such as baclofen, tizanidine or diazepam can ease stiffness and spasms; the dose is adjusted to balance relief against side effects such as sleepiness. Seizures, more common in the connatal form, are usually controlled with standard anti-seizure medicines. Speech therapy and communication aids help people express what they understand. Swallowing problems are common as the condition progresses. Feeding therapy can make eating safer, and some people need a feeding tube placed in the stomach (gastrostomy) to get enough nutrition and reduce the risk of food or liquid entering the lungs. Curving of the spine (scoliosis) and joint contractures may need careful seating, physical therapy or surgery. Bone density, vision and bladder function are also monitored and treated as needed. Research is active. An early-stage clinical trial began in 2024 testing an antisense medicine, a treatment designed to lower production of the PLP1 protein, delivered into the spinal fluid. This trial is checking safety, and it is too early to know whether it will help.

What to Expect

The course of PMD depends heavily on the form. In classic PMD, children typically keep gaining skills slowly through childhood, though many need help to walk or never walk independently. Development often levels off around adolescence, after which skills are gradually lost. Nystagmus may fade, while stiffness and other movement problems increase. People with classic PMD often live into adulthood, from their 20s to, in some cases, their 60s. The connatal form progresses faster: children usually never walk, may have trouble swallowing and breathing from early on, and often do not survive beyond the teenage years. Research suggests that noisy breathing (stridor) at the start and not gaining head control by 12 months are linked with more severe outcomes, which can help families plan. Still, no single sign predicts an individual child's course. Daily life usually involves a steady routine of therapy, equipment and medical appointments, with growing support needs over time. Many people with PMD communicate, enjoy relationships and take part in school or programs adapted to their abilities. Regular follow-up checks growth and feeding, movement, seizures, the spine and hips, vision, and bladder function. Fever can temporarily make neurological symptoms worse, and the worsening usually eases as the fever passes, though the fever itself may still need checking, especially with breathing or feeding problems. Caring for someone with PMD is demanding. Social work, respite care, rare disease organizations and genetic counseling can help families manage practical needs and plan ahead.

When to Seek Help

See a pediatrician or neurologist if a baby has rapid, jerky eye movements, unusually floppy muscles or delays in head control and sitting, especially if a male relative on the mother's side had a similar condition. Women with a family history of PMD may want genetic counseling before or during pregnancy. For someone already diagnosed, contact the care team promptly about new or more frequent seizures, coughing or choking with meals, weight loss, frequent chest infections or noisier, harder breathing, because breathing complications are a leading cause of serious illness in PMD. Also raise any loss of skills that seems faster than expected, or new pain, stiffness or hip or spine problems. Call 911 if they are struggling to breathe, their lips or face turn blue or gray, or a seizure lasts longer than 5 minutes (or follow the seizure plan the care team has given).

Questions to Ask Your Doctor

  1. 1.Which form of PMD does this appear to be, and what does that suggest about the likely course?
  2. 2.Which specialists and therapies should be part of the care team now, and how often should we be seen?
  3. 3.What signs of swallowing or breathing trouble should we watch for, and when would a feeding tube or breathing support be considered?
  4. 4.What does this genetic result mean for other family members and future pregnancies?
  5. 5.Are there clinical trials or research registries that might be appropriate?

Last reviewed • Oct 2026

Educational content, not medical advice.